Evaluation of the Risk Associated With Impulsivity & Other

Status Recruiting

Clinical Trial Summary

Suicidal behavior (SB) is a major public health problem in France, with over 10,000 suicides (6th in the EU28) and 220,000 suicide attempts (SA) per year. These data seem underestimated by 20%. A large percentage of men (6%) and women (9%) in France made at least one lifetime SA. In addition, SBs are common among young people and are the second leading cause of death among 15-44 year-olds. The interaction of multiple factors in SB complicates the creation of predictive models. These are currently imprecise and prevent the development of consensual recommendations for the management of suicidal patients. Most suicide attempters are evaluated in the emergency room where it is imperative to identify people with a high risk of relapse. Risk assessment is generally based on the experience of the practitioner who uses psychometric scales as support for clinical decisions. This assessment could be improved and supplemented by other sources of information. Thus, we aim to develop a short and specific tool that combines: 1. Neurocognitive measures carried out using computer software on domains strongly associated with SB: impulsivity, affective dysregulation, alterations in decision-making (risky choices), selective attention and verbal fluency. 2. Clinical and psychological assessment including the most predictive items of future SA: life events (environment) and personality traits (vulnerability). Suicide attempters will be assessed for SB and suicidal ideation in the emergency department. These measures will be repeated during a 12-month follow-up. We will use the data obtained to provide a more accurate measure of risk.

Clinical Trial Description

Over 65 months, 5 emergency departments (Montpellier, Nimes, Uzès, Nice, Marseille) will recruit a total of 650 patients who attempted suicide. - First visit: clinical and neuropsychological assessment - Second and third visits at 6 and 12 months: assessment of SBs and suicidal relapse, clinical and neuropsychological assessment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03026387
Study type	Interventional
Source	University Hospital, Montpellier
Contact	Jorge LOPEZ-CASTROMAN, MD
Phone	+33 4 66 68 34 26
Email	jorge.lopezcastroman@chu-nimes.fr
Status	Recruiting
Phase	N/A
Start date	May 5, 2017
Completion date	October 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05848089` - Real-time Intervention for Suicide Risk Reduction	N/A
Not yet recruiting	`NCT04686162` - Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy	N/A
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Recruiting	`NCT04770168` - Harry Potter as a Novel Educational Paradigm to Improve Mental Wellness in Children: A Prospective Trial	N/A
Completed	`NCT03427190` - Suicide Prevention Algorithm in the French Overseas Territories	N/A
Recruiting	`NCT05996172` - Swift Outpatient Alternatives for Rapid Stabilization	N/A
Not yet recruiting	`NCT06378541` - Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)	N/A
Recruiting	`NCT04585802` - Expansion and Reevaluation of the Implicit Association Test in Suicide Ideators and Suicide Attempters
Completed	`NCT01398891` - Development of a Positive Psychology Intervention to Reduce Suicide Risk	N/A
Completed	`NCT00735540` - Clinical Diagnosis of Teenagers Admitted to Pediatric Departments	N/A
Completed	`NCT01502436` - An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
Completed	`NCT00736918` - RCT of Post-Suicide Attempt Case Management (ACTION-J)	Phase 3
Completed	`NCT02414763` - Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors	Phase 1
Completed	`NCT02505373` - ASSIP, Attempted Suicide Short Intervention Program. Two Year Follow-Up Study	N/A
Completed	`NCT02887170` - The 10-years REPEATERS Cohort of French Adolescents
Recruiting	`NCT06233747` - Improving Care, Accelerating Recovery and Education	N/A
Recruiting	`NCT06223867` - Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A	N/A
Completed	`NCT05158946` - A Future-oriented Group Training for Suicidal Patients	N/A
Recruiting	`NCT05955807` - Momentary Assessment.Tracking Suicidal Ideation
Recruiting	`NCT05707975` - Eco-anxiety and Suicide

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of the Risk Associated With Impulsivity and Other Neuropsychological Factors on Suicidal Relapse Within Hospital Emergencies — SUI-PREDICT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms